The POINT project seeks to develop innovative strategies for the prevention and management of non-communicable diseases that arise as complications during the post-acute phase of COVID-19.
Oculis touts Phase 2 results in dry eye disease, but most data aren’t statistically significant
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS